Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report. | BMC Infect Dis | 2023 | 37024850 | PubTator, text mining | PubMed |
| Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. | Nat Commun | 2023 | 37019972 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia. | Open Med (Wars) | 2023 | 37016705 | PubTator, text mining | PubMed |
| Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study. | J Cancer Res Ther | 2023 | 37006070 | PubTator, text mining | PubMed |
| Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a. | J Transl Med | 2023 | 37004031 | PubTator, text mining | PubMed |
| Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. | Int J Mol Sci | 2023 | 36982453 | PubTator, text mining | PubMed |
| The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia. | Genes (Basel) | 2023 | 36980962 | PubTator, text mining | PubMed |
| Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients. | Cancers (Basel) | 2023 | 36980682 | PubTator, text mining | PubMed |
| Polycomb Alterations in Acute Myeloid Leukaemia: From Structure to Function. | Cancers (Basel) | 2023 | 36980579 | PubTator, text mining | PubMed |
| A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 36980551 | PubTator, text mining | PubMed |
| Progress toward Better Treatment of Therapy-Related AML. | Cancers (Basel) | 2023 | 36980546 | PubTator, text mining | PubMed |
| In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation. | Cells | 2023 | 36980237 | PubTator, text mining | PubMed |
| Telomere Transcription in MLL-Rearranged Leukemia Cell Lines: Increased Levels of TERRA Associate with Lymphoid Lineage and Are Independent of Telomere Length and Ploidy. | Biomedicines | 2023 | 36979904 | PubTator, text mining | PubMed |
| Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment. | Biology (Basel) | 2023 | 36979159 | PubTator, text mining | PubMed |
| Intracellular Antibodies for Drug Discovery and as Drugs of the Future. | Antibodies (Basel) | 2023 | 36975371 | PubTator, text mining | PubMed |
| Acute pancreatitis as the initial manifestation of acute myeloid leukemia with chromosome 16 rearrangements. | Int J Hematol | 2023 | 36964839 | PubTator, text mining | PubMed |
| Prediction model for drug response of acute myeloid leukemia patients. | NPJ Precis Oncol | 2023 | 36964195 | PubTator, text mining | PubMed |
| [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 36948866 | PubTator, text mining | PubMed |
| Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study. | Blood Adv | 2023 | 36939402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=17